Oppenheimer & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Oppenheimer & Co’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,263	Closed	-$261K	–	1524
2020 Q4	$261K	Sell	2,263 -1,257	-36%	-$141K	0.01%	1139
2020 Q3	$343K	Buy	3,520 +494	+16%	+$56.8K	0.01%	933
2020 Q2	$371K	Buy	3,026 +578	+24%	+$65.6K	0.01%	897
2020 Q1	$214K	Sell	2,448 -384	-14%	-$40.7K	0.01%	1012
2019 Q4	$296K	Buy	+2,832	New	+$318K	0.01%	1028
2019 Q3	–	Sell	-1,360	Closed	-$234K	–	1349
2019 Q2	$234K	Buy	1,360 +18	+1%	+$3.11K	0.01%	1118
2019 Q1	$226K	Buy	+1,342	New	+$200K	0.01%	1167
2018 Q4	–	Sell	-1,185	Closed	-$205K	–	1397
2018 Q3	$205K	Buy	+1,185	New	+$171K	0.01%	1219

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer & Co's GWPH Position: Q1 2021 in Review

Oppenheimer & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,263 shares — an estimated $261K sold.

Oppenheimer & Co first reported a position in GWPH in Q3 2018 and held it in 8 quarters. The position peaked at $371K in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Oppenheimer & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Oppenheimer & Co sold 2,263 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $261K.
Oppenheimer & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 8 quarters.
Oppenheimer & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $371K in Q2 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Oppenheimer & Co's 13F filing for Q1 2021, filed 10 May 2021.